Leigh Spielberg
Published: Saturday, June 1, 2019
Macular haemorrhage remains one of the most difficult ophthalmic entities to manage, so I jumped at the chance to review
Management of Macular Hemorrhage (Springer).
As a vitreoretinal surgeon myself who often encounters this pathology, I could always learn more.
Edited by Lars-Olof Hattenbach, this 93-page book quickly points out that “there is currently no consensus regarding the ideal treatment for macular hemorrhage”. There are indeed no easy-to-follow recipes for success.
Instead, the text aims to “provide a systematic overview of therapeutic approaches that cover the most important situations a vitreoretinal surgeon might encounter when treating patients with this disorder”.
Macular haemorrhage, which is a severe complication of a variety of ocular disorders such as AMD, arterial macroaneurysm and valsalva retinopathy, used to spell the absolute end of useful central visual acuity. However, since the development of various techniques involving intravitreal or subretinal injection of rtPA, choroidal-RPE grafts, gas tamponade and anti-VEGF, the prognosis is significantly better, although still highly variable and frustratingly unpredictable.
This book covers not only the surgical techniques but the indications for surgery, making it useful not only for retinal specialists but also for general ophthalmologists interested in providing their patients with correct and efficient referrals in a timely fashion.
Tags: Macular haemorrhage
Latest Articles
Towards a Unified IOL Classification
The new IOL functional classification needs a strong and unified effort from surgeons, societies, and industry.
Read more...
Organising for Success
Professional and personal goals drive practice ownership and operational choices.
Read more...
Is Frugal Innovation Possible in Ophthalmology?
Improving access through financially and environmentally sustainable innovation.
Read more...
iNovation Innovators Den Boosts Eye Care Pioneers
New ideas and industry, colleague, and funding contacts among the benefits.
Read more...
From Concept to Clinic
Partnerships with academia and industry promote innovation.
Read more...
José Güell: Trends in Cornea Treatment
Endothelial damage, cellular treatments, human tissue, and infections are key concerns on the horizon.
Read more...
Making IOLs a More Personal Choice
Surgeons may prefer some IOLs for their patients, but what about for themselves?
Read more...
Need to Know: Higher-Order Aberrations and Polynomials
This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.
Read more...
Never Go In Blind
Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.
Read more...